Close



Apr 2, 2024 08:00AM
Mar 12, 2024 08:00AM
Jan 26, 2024 07:30AM
Jan 26, 2024 07:30AM
Jan 23, 2024 08:00AM
Jan 9, 2024 08:00AM
Dec 18, 2023 08:00AM Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO GU
Nov 7, 2023 08:00AM
Oct 3, 2023 08:00AM
Aug 8, 2023 08:00AM
May 9, 2023 08:00AM
Feb 13, 2023 06:56AM
Feb 13, 2023 06:55AM
Mar 2, 2022 07:02AM Akari Therapeutcis (AKTX) Appoints Rachelle Jacques as President and CEO
Mar 2, 2022 07:00AM
Nov 16, 2021 08:45AM
Nov 12, 2021 08:05AM
Aug 12, 2021 08:05AM
Aug 12, 2021 08:05AM
Jun 24, 2021 08:06AM
Jun 24, 2021 08:05AM Corbus Pharmaceuticals Announces Topline Results from DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
Jun 24, 2021 08:05AM
Apr 20, 2021 08:08AM
Apr 20, 2021 08:05AM
Apr 20, 2021 08:05AM
Mar 30, 2021 08:08AM
Mar 30, 2021 08:05AM
Mar 30, 2021 08:05AM Corbus Pharmaceuticals Reports Last Subject Visit in DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
Dec 21, 2020 08:59AM
Nov 10, 2020 07:05AM
Nov 10, 2020 07:05AM
Nov 9, 2020 08:05AM
Nov 9, 2020 08:05AM
Oct 21, 2020 08:07AM
Oct 21, 2020 08:05AM Corbus Pharmaceuticals Announces Three Lenabasum Abstracts to be Presented at ACR Convergence 2020
Oct 21, 2020 08:05AM
Oct 6, 2020 09:34AM
Sep 8, 2020 09:26AM
Sep 8, 2020 07:10AM
Sep 8, 2020 07:05AM
Sep 8, 2020 07:05AM
Aug 6, 2020 07:05AM Corbus Pharmaceuticals Reports Second Quarter Financial Results and Corporate Updates
Aug 6, 2020 07:05AM
Aug 5, 2020 09:30AM
Aug 5, 2020 09:25AM
Aug 5, 2020 09:25AM
Jul 7, 2020 09:32AM
Jun 22, 2020 08:08AM
Jun 22, 2020 08:05AM Corbus Pharmaceuticals Reports Last Subject Visit in Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis
Jun 22, 2020 08:05AM

251,009 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All